# Divalent metal cations stimulate skeleton interoception for new bone formation in mouse injury models

**Authors:** Wei Qiao, Dayu Pan, Yufeng Zheng, Shuilin Wu, Xuanyong Liu, Zhuofan Chen, Mei Wan, Shiqin Feng, Kenneth M. C. Cheung, Kelvin W. K. Yeung, Xu Cao

PMC · DOI: 10.1038/s41467-022-28203-0 · Nature Communications · 2022-01-27

## TL;DR

Divalent metal cations promote new bone formation by activating a nerve and immune cell pathway in mice.

## Contribution

The study reveals that divalent cations stimulate bone growth through a skeleton interoceptive circuit involving immune and nerve cells.

## Key findings

- Divalent cations promote prostaglandin E2 secretion from macrophages, stimulating skeleton interoception.
- Activation of skeleton interoception reduces sympathetic tone to support new bone formation.
- Macrophage depletion or sensory nerve knockout eliminates the osteogenic effects of divalent cations.

## Abstract

Bone formation induced by divalent metal cations has been widely reported; however, the underlying mechanism is unclear. Here we report that these cations stimulate skeleton interoception by promoting prostaglandin E2 secretion from macrophages. This immune response is accompanied by the sprouting and arborization of calcitonin gene-related polypeptide-α+ nerve fibers, which sense the inflammatory cue with PGE2 receptor 4 and convey the interoceptive signals to the central nervous system. Activating skeleton interoception downregulates sympathetic tone for new bone formation. Moreover, either macrophage depletion or knockout of cyclooxygenase-2 in the macrophage abolishes divalent cation-induced skeleton interoception. Furthermore, sensory denervation or knockout of EP4 in the sensory nerves eliminates the osteogenic effects of divalent cations. Thus, our study reveals that divalent cations promote bone formation through the skeleton interoceptive circuit, a finding which could prompt the development of novel biomaterials to elicit the therapeutic power of these divalent cations.

Mechanisms underlying bone formation induced by divalent metal cations remain largely unknown. Here the authors show that these cations can activate the skeleton interoceptive circuit through the immune-neural axis to initiate new bone formation.

## Linked entities

- **Genes:** PTGER4 (prostaglandin E receptor 4) [NCBI Gene 5734]
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Ptgs2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 19225] {aka COX2, Cox-2, PES-2, PGHS-2, PHS II, PHS-2}, Htr2c (5-hydroxytryptamine (serotonin) receptor 2C) [NCBI Gene 15560] {aka 5-HT-1C, 5-HT-2C, 5-HT1C, 5-HT2C, 5-HT2cR, 5-HTR2C}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Npy (neuropeptide Y) [NCBI Gene 109648] {aka 0710005A05Rik}, Ngf (nerve growth factor) [NCBI Gene 18049] {aka Ngfb, beta-NGF}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Ptger4 (prostaglandin E receptor 4) [NCBI Gene 84023] {aka EP4, Ptger, Ptgerep4}, Ptger4 (prostaglandin E receptor 4 (subtype EP4)) [NCBI Gene 19219] {aka EP4, Ptgerep4}, Cd19 (CD19 antigen) [NCBI Gene 12478], Dnase1 (deoxyribonuclease I) [NCBI Gene 13419] {aka DNaseI, Dnl1}, Rela (Rela proto-oncogene, NFKB subunit) [NCBI Gene 19697] {aka p65, p65 NF-kappa B, p65 NFkB}, Tnfsf11 (tumor necrosis factor (ligand) superfamily, member 11) [NCBI Gene 21943] {aka Ly109l, ODF, OPGL, RANKL, Trance}, Pecam1 (platelet/endothelial cell adhesion molecule 1) [NCBI Gene 18613] {aka Cd31, PECAM-1, Pecam}, Ptges (prostaglandin E synthase) [NCBI Gene 64292] {aka 2410099E23Rik, D2Ertd369e, Pges, mPGES, mPGES-1}, Runx2 (runt related transcription factor 2) [NCBI Gene 12393] {aka AML3, CBF-alpha-1, Cbf, Cbfa-1, Cbfa1, LS3}, Csf1 (colony stimulating factor 1 (macrophage)) [NCBI Gene 12977] {aka BAP025, Csfm, MCSF, Mhdabap25, PG-M-CSF, op}, Nfkbia (nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha) [NCBI Gene 18035] {aka Nfkbi}, Calca (calcitonin/calcitonin-related polypeptide, alpha) [NCBI Gene 12310] {aka CA, CGRP-1, CGRP1, Calc, Calc1, Cgrp}, Uchl1 (ubiquitin carboxy-terminal hydrolase L1) [NCBI Gene 22223] {aka PGP 9.5, PGP9.5, UCH-L1, UCHL-1, gad}, Itgax (integrin alpha X) [NCBI Gene 16411] {aka Cd11c, Cr4, N418}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Sp7 (Sp7 transcription factor 7) [NCBI Gene 170574] {aka 6430578P22Rik, C22, Osx}, Adrb2 (adrenergic receptor, beta 2) [NCBI Gene 11555] {aka Adrb-2, Badm, Gpcr7}, Trpm7 (transient receptor potential cation channel, subfamily M, member 7) [NCBI Gene 58800] {aka 2310022G15Rik, 4833414K03Rik, 5033407O22Rik, CHAK, CHAK1, LTrpC-7}, Lyz2 (lysozyme 2) [NCBI Gene 17105] {aka Lys, Lysm, Lyzf2, Lyzs, Lzm, Lzm-s1}, CBR1 (carbonyl reductase 1) [NCBI Gene 873] {aka CBR, PG-9-KR, SDR21C1, hCBR1}, Cd3e (CD3 antigen, epsilon polypeptide) [NCBI Gene 12501] {aka CD3, CD3epsilon, T3e}, Avil (advillin) [NCBI Gene 11567] {aka Advil, DOC6}, Acp5 (acid phosphatase 5, tartrate resistant) [NCBI Gene 11433] {aka TRACP, TRAP}, Adgre1 (adhesion G protein-coupled receptor E1) [NCBI Gene 13733] {aka DD7A5-7, EGF-TM7, Emr1, F4/80, Gpf480, Ly71}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Th (tyrosine hydroxylase) [NCBI Gene 21823], Bglap2 (bone gamma-carboxyglutamate protein 2) [NCBI Gene 12097] {aka BGP2, Bglap1, Bgp, Og2, mOC-B}, Creb1 (cAMP responsive element binding protein 1) [NCBI Gene 12912] {aka 2310001E10Rik, 3526402H21Rik, Creb, Creb-1}, Ntrk1 (neurotrophic tyrosine kinase, receptor, type 1) [NCBI Gene 18211] {aka Tkr, TrkA, trk}, Calca (calcitonin-related polypeptide alpha) [NCBI Gene 24241] {aka CAL6, CGRP, CGRP1, Cal1, Calc, RATCAL6}, Emcn (endomucin) [NCBI Gene 59308] {aka 0610012K22Rik, Muc14}, PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 5743] {aka COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2}
- **Diseases:** spinal hypersensitivity (MESH:D004342), postoperative pain (MESH:D010149), bone injury (MESH:D001847), cytotoxicity (MESH:D064420), musculoskeletal injuries (MESH:D009140), decreased bone formation (MESH:D058426), cortical bone thickening (MESH:C563483), resorption (MESH:D014091), inflammation (MESH:D007249), pain (MESH:D010146), BMM (MESH:D001855), bone fracture (MESH:D050723),  (MESH:D004195)
- **Chemicals:** PBS (MESH:D007854), PVP (MESH:D011205), magnesium (MESH:D008274), PGE2 (MESH:D015232), saline (MESH:D012965), H&amp;E (MESH:D006371), water (MESH:D014867), Cu2+ (-), CuCl2 (MESH:C029892), formaldehyde (MESH:D005557), calcein (MESH:C007740), copper (MESH:D003300), sodium dodecyl sulfate (MESH:D012967), cation (MESH:D002412), calcein green (MESH:C083098), ethylenediaminetetraacetic acid (MESH:D004492), epinephrine (MESH:D004837), zinc (MESH:D015032), paraformaldehyde (MESH:C003043), Alexa-Fluor 488 (MESH:C000711379), celecoxib (MESH:D000068579), serotonin (MESH:D012701), ethanol (MESH:D000431), CO2 (MESH:D002245), hematoxylin (MESH:D006416), SYBR Green (MESH:C098022), MgCl2 (MESH:D015636), xylenol (MESH:C016834), Methyl green (MESH:D008739), metal (MESH:D008670), polyacrylamide (MESH:C016679), Alexa-Fluor 647 (MESH:C569686), sucrose (MESH:D013395), Agarose (MESH:D012685), alginate (MESH:D000464), Rompun (MESH:D014991), Propranolol (MESH:D011433), eosin (MESH:D004801), paraffin (MESH:D010232), Divalent cation (MESH:D002413), alpha-MEM (MESH:C420642), SW033291 (MESH:C000599192), xylenol orange (MESH:C016833), Ketalar (MESH:D007649), ZnCl2 (MESH:C016837),  (MESH:D002116)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** 387A — Mus musculus (Mouse), Hybridoma (CVCL_KS96)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC8795158/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC8795158/full.md

## References

81 references — full list in the complete paper: https://tomesphere.com/paper/PMC8795158/full.md

---
Source: https://tomesphere.com/paper/PMC8795158